Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2a Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

NCT03080298 is registered in ClinicalTrials.gov with Ivix LLX as lead sponsor.

NCT NCT03080298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2a Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
Lead sponsor
Ivix LLX
Phase
Phase 2
Overall status
Completed
Start date
March 14, 2016
Completion date
July 25, 2017
Enrollment
119 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hypoactive sexual desire disorder (hsdd)